Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease

BMC Gastroenterology

Volumn 14, Issue 1, 2014, Pages

  Haflidadottir, Svanhildur ^a   Jonasson, Jon G ^a,b   Norland, Helga ^b   Einarsdottir, Sylvia O ^a   Kleiner, David E ^c   Lund, Sigrun H ^b   Björnsson, Einar S ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AFLD; Fibrosis; Mortality; NAFLD; Prognosis

Indexed keywords

ADULT; ALCOHOLIC FATTY LIVER; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; ICELAND; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NONALCOHOLIC FATTY LIVER; POPULATION RESEARCH; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL TIME; AGED; COMPLICATION; DISEASE COURSE; LIVER CIRRHOSIS, ALCOHOLIC; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; DISEASE PROGRESSION; FATTY LIVER, ALCOHOLIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84910025836     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-14-166     Document Type: Article

References (28)

1. Bellantini S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010, 28:155-161.
2. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008, 28:339-350.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
4. Friis-Liby I, Aldenborg F, Jerlstad P, Rundström K, Björnsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2004, 39:864-869.
5. Day PC. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going. Gut 2002, 50:585.
6. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
7. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
8. Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sörensen TIA, Becker U, Bendtsen F. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004, 53:750-755.
9. Jepsen P, Vilstrup H, Mellemkjær L, Thulstrup AM, Olsen JH, Baron JA, Sörensen HT. Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study. Hepato-Gastroenterology 2003, 50:2101-2104.
10. Dam-Larsen S, Becker U, Franzmann MB, Larsen K, Christoffersen P, Bendtsen F. Final results of long-term, clinical follow-up in fatty liver patients. Scand J Gastroenterol 2009, 44:1236-1243.
11. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
12. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
13. Statistics Iceland 2013, Available from: http://www.hagstofan.is/Hagtolur/Mannfjoldi/faeddir-og-danir, Statistics Iceland.
14. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease. A spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
15. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008, 49:608-612.
16. Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R. Decreased survival of subjects with elevated liver function tests during a 28-year old follow up. Hepatology 2010, 51:595-602.
17. Lee GR. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989, 20:594.
18. Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci 1995, 40:1805-1815.
19. Bellantini S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112-117.
20. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput J. Excess weight risk factor for alcoholic liver disease. Hepatology 1997, 25:108-111.
21. Gunnarsdottir SA, Olsson R, Olafsson S, Cariglia N, Westin J, Thjodleifsson B, Björnsson E. Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes. Scand J Gastroenterol 2009, 44:984-993.
22. Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta M, Unalp-Arida A, Tonascia J, Zein CO, Brunt EM, Kleiner DE, McCullough AJ, Sanyal AJ, Diehl AM, Lavine JE, Chalasani N, Kowdley KV. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010, 52:913-924.
23. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992, 117:646-654.
24. Becker U, Deis A, Sorensen TIA, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996, 23:1025-1029.
25. Kamper-Jorgensen M, Gronbaek M, Tolstrup J, Becker U. Alcohol and cirrhosis: dose-response or threshold effect?. J Hepatology 2004, 41:25-30.
26. Deleuran T, Grønbæk H, Vilstrup H, Jepsen P. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study. Aliment Pharmacol Ther 2012, 35:1336.
27. Angulo P, Bugianesi E, Björnsson E, Charatcharoenwitthaya P, Mills PR, Barrera F, Haflidadottir S, Day CS. Simple non-invasive systems predict long-term outcomes in patients with nonalcoholic fatty liver disease. Gastroenterology 2013, 145:782-789.
28. Prytz H, Skinhoj P. Morbidity, mortality, and incidence of cirrhosis in Denmark 1976-1978. Scan J Gastroent 1981, 16:839-844.